Ondine Biomedical (FRA:VF5) OCF Margin %: -706.14% (As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical OCF Margin %?

Ondine Biomedical FRA:VF5 47 OCF Margin % is -706.14% as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ondine Biomedical's Cash Flow from Operations for the six months ended in Dec. 2024 was €-5.64 Mil. Ondine Biomedical's Revenue for the six months ended in Dec. 2024 was €0.80 Mil. Therefore, Ondine Biomedical's OCF Margin % for the quarter that ended in Dec. 2024 was -706.14%.

As of today, Ondine Biomedical's current OCF Yield % is -15.63%.

The historical rank and industry rank for Ondine Biomedical's OCF Margin % or its related term are showing as below:

FRA:VF5' s OCF Margin % Range Over the Past 10 Years
Min: -2707.31   Med: -945.65   Max: -177.44
Current: -756.3

During the past 13 years, the highest OCF Margin % of Ondine Biomedical was -177.44%. The lowest was -2707.31%. And the median was -945.65%.

FRA:VF5's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs FRA:VF5: -756.30

Ondine Biomedical OCF Margin % Related Terms

Ondine Biomedical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical OCF Margin % Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -349.61 -488.18 -2,563.88 -1,135.28 -756.23

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,116.86 -1,912.12 -706.60 -825.09 -706.14

FRA:VF5 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Ondine Biomedical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's OCF Margin % falls into.


FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Ondine Biomedical's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-10.383/1.373
=-756.23 %

Ondine Biomedical's OCF Margin for the quarter that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-5.635/0.798
=-706.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -706.14% mean?
Ondine Biomedical (FRA:VF5) has a OCF Margin % of -706.14% as of Dec. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's OCF Margin % too high?
Ondine Biomedical's current OCF Margin % is -706.14%. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's OCF Margin % compare to VRTX and REGN?
Ondine Biomedical's OCF Margin % of -706.14% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current OCF Margin % is -706.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current OCF Margin % of -706.14%. The current OCF Margin % is -706.14%. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current OCF Margin % is -706.14% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price